In a communication to Dr V K Paul, the convenor of a key empowered group on Covid vaccination, on Tuesday, the Ministry of External Affairs said many issues about vaccines and international travel by Indians have arisen and these must be addressed immediately. Bharat Biotech Must Address WHO s COVID-19 Vaccine Covaxin Supply Suspension to Avoid Emergency Use Listing Cancellation in Future, Says MEA.
"Received some feedback. will do those modifications. WHO has said nothing related to safety or efficacy," sources in Bharat Biotech told ANI. "It s (WHO post- Emergency Use Authorization inspection) a routine inspection for Covaxin," sources added. Bharat Biotech to Rectify Issues Raised by WHO on COVID-19 Vaccine Covaxin Soon: Sources.
It also informed that another batch of additional 5,00,000 doses would be supplied in the coming weeks. The last batch of humanitarian assistance consisting of 5,00,000 doses of Covaxin was supplied to Afghanistan on January 1. India Supplies 5 Lakh More COVID-19 Vaccine Covaxin Doses to Afghanistan.
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.